Table 1

Patient demographics and baseline characteristics observed within 60 days before to 30 days after the index date

ParameterExenatideSitagliptinInsulin
n6,2805,86132,398
Age (years)57 ± 11.062 ± 11.861 ± 13.7
Sex (% female)594952
BMI (kg/m2)38.5 ± 7.9433.8 ± 7.5133.6 ± 8.29
Weight (kg)110 ± 24.797 ± 23.496 ± 25.0
Charlson score0.52 ± 1.080.74 ± 1.290.63 ± 1.26
Medications (%)
    Antihypertensive drug(s)545471
    Lipid-lowering drug504955
    Sulfonylurea242215
    Metformin444020
    Thiazolidinediones232213
    No other OADs414266
    1 other OAD333621
    2 other OADs201811
    3 other OADs653
    ≥4 other OADs<1<1<1
Payer type (%)
    Commercial484029
    Medicaid<1<13
    Medicare173030
    Self<1<11
    Unknown332938
  • Data are means ± SD unless otherwise indicated.